An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation

An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation

BackgroundLaboratory activated partial thromboplastin time (LAB-aPTT) is a widely used laboratory assay for monitoring unfractionated heparin (UFH) therapy during extracorporeal membrane oxygenation (ECMO). But LAB-aPTT is confined to a central laboratory, and the procedure is time-consuming. In com...

Full description

Bibliographic Details
Main Authors: Yuan Teng, Shujie Yan, Gang Liu, Song Lou, Yang Zhang, Bingyang Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Subjects:
activated partial thromboplastin time
point of care
extracorporeal membrane oxygenation
anticoagulation
unfractionated heparin
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.931863/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.931863/full

Similar Items